Immunic, inc. added to nasdaq biotechnology index

New york, dec. 14, 2020 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that it has been selected for...

IMUX Ratings Summary

IMUX Quant Ranking